- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06595914
Improving In-hospital and Post-discharge Patient Education for Mild Traumatic Brain Injury (EDucate)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Medical College of Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
ED clinicians:
• Faculty attending physician, advanced practice professional (APP), resident, fellow, or nurse who practices in an eligible Froedtert & Medical College of Wisconsin (MCW) emergency department
Patients-Survey Cohort:
- Seen and discharged from a Froedtert & MCW emergency department.
- Age 18 or older.
- Has a clinical diagnosis of TBI, as reflected by a relevant International Classification of Disease-10th Edition (ICD-10) code or other evidence (e.g., diagnosis and educational information in the After Visit Summary)
- Speaks English or Spanish.
Patients-Chart Review Only:
- Seen and discharged from a Froedtert & MCW emergency department.
- Age 18 or older.
- Has a clinical diagnosis of TBI, as reflected by a relevant ICD-10 code or other evidence (e.g., diagnosis and educational information in the After Visit Summary). Note that for evaluation of Secondary Aim #1 (% trauma patients with an mTBI diagnosis), a broader sample of emergency department patients evaluated for trauma will be evaluated).
Exclusion Criteria:
ED clinicians:
• Providers that do not practice in a Froedtert & Medical College of Wisconsin emergency department.
Patients-Survey Cohort.
- In protective custody.
- On psychiatric hold.
- Is not own decision maker (e.g., activated healthcare power of attorney).
- Indicated Do Not Contact in their research contact preferences.
- Left the emergency department prematurely (e.g., against medical advice).
- History of serious health condition that, in the opinion of the investigator, would interfere with engagement in or validity of the survey (e.g., active thought disorder; terminal cancer; dementia).
Patients-Chart Review Only:
• Minors under the age of 18.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Clinicians
Clinician participants will all have access to any clinical implementation strategies that are developed and disseminated in the project.
|
Clinical implementation strategies, selected based on ED clinician survey/interview findings from Aim 1 using the Implementing Promoting Action on Research Implementation in Health Services (i-PARIHS) implementation science framework
|
|
No Intervention: Patients-Survey Cohort
Patient participants will be observationally followed via survey during the study to monitor patient-reported outcomes.
|
|
|
No Intervention: Patients-Chart Review Only
Patients who are not in the survey study but who meet other eligibility criteria will undergo chart review to provide electronic health record-based outcomes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in patient-level penetration-electronic health record (EHR)
Time Frame: Pre-intervention baseline period (estimated study onset to 1 year later); post- intervention follow-up period (estimated 18 months from study onset to 1 year later)
|
Change in the percentage of concussion/mTBI-related encounters for which an mTBI patient handout was documented in the Epic After Visit Summary (Aim 2 outcome)
|
Pre-intervention baseline period (estimated study onset to 1 year later); post- intervention follow-up period (estimated 18 months from study onset to 1 year later)
|
|
Change in patient-level penetration-patient reported outcome (PRO)
Time Frame: Pre-intervention baseline period (estimated study onset to 1 year later); post- intervention follow-up period (estimated 18 months from study onset to 1 year later)
|
Change in the percentage of concussion/mTBI-related encounters for which patients reported having received mTBI patient education before ED discharge (Aim 2 outcome)
|
Pre-intervention baseline period (estimated study onset to 1 year later); post- intervention follow-up period (estimated 18 months from study onset to 1 year later)
|
|
Self-efficacy to manage mTBI symptoms
Time Frame: Day 1 post-ED visit, Day 30 post-ED visit
|
Patient ratings on the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Self-Efficacy for Managing Symptoms, a 20-point scale based on 4 Likert-type items with 5 response options each (higher scores = more confidence) (Aim 3 outcome).
|
Day 1 post-ED visit, Day 30 post-ED visit
|
|
mTBI symptom burden
Time Frame: Day 1 post-ED visit, Day 30 post-ED visit
|
Patient-rated Rivermead Post Concussion Symptoms Questionnaire total score (range 0-64; higher scores = more severe injury-related symptoms) (Aim 3 outcome).
|
Day 1 post-ED visit, Day 30 post-ED visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in percentage of trauma cases resulting in mTBI diagnosis
Time Frame: Pre-intervention baseline period (estimated study onset to 1 year later); post-intervention follow-up period (estimated 18 months from study onset to 1 year later)
|
Change in the percentage of ED encounters for a traumatic injury resulting in a diagnosis of concussion or mTBI
|
Pre-intervention baseline period (estimated study onset to 1 year later); post-intervention follow-up period (estimated 18 months from study onset to 1 year later)
|
|
Patient-rated clinical care satisfaction at Day 1
Time Frame: Day 1 post-ED visit
|
Collected on a 5-point scale with the options Very Satisfied, Somewhat Satisfied, Neither Satisfied Nor Dissatisfied, Somewhat Dissatisfied, and Very Dissatisfied.
The question is "How satisfied are you with the care you received for head injury in the Emergency Department?"
|
Day 1 post-ED visit
|
|
Patient-rated clinical care satisfaction at Day 30
Time Frame: Day 30 post-ED visit
|
Collected on a 5-point scale with the options Very Satisfied, Somewhat Satisfied, Neither Satisfied Nor Dissatisfied, Somewhat Dissatisfied, and Very Dissatisfied.
The question is "How satisfied are you with the care you received for head injury since leaving the emergency department?"
|
Day 30 post-ED visit
|
|
Patient-rated mTBI knowledge
Time Frame: Day 30 post-ED visit
|
Patient-rated mTBI knowledge, measured with a 24-item True/False scale (total score range 0-24; higher scores = greater knowledge).
Questions ask about common and uncommon mTBI symptoms and common misconceptions about mTBI signs and recovery.
|
Day 30 post-ED visit
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in clinician ratings to the Acceptability of Intervention Measure
Time Frame: Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)
|
ED clinician responses to the Acceptability of Intervention Measure (AIM), a 4 item scale with 5-point Likert-type items scaled from 1 (completely disagree) to 5 (completely agree).
Total scores reflect the mean item rating (range 1 to 5); higher scores reflect greater acceptability.
(Aim 2 outcome; Aim 1 will characterize pre-implementation baseline data only)
|
Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)
|
|
Change in clinician ratings to the Intervention Appropriateness Measure
Time Frame: Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)
|
ED clinician responses to the Intervention Appropriateness Measure (IAM), a 4 item scale with 5-point Likert-type items scaled from 1 (completely disagree) to 5 (completely agree).
Total scores reflect the mean item rating (range 1 to 5); higher scores reflect greater appropriateness.
(Aim 2 outcome; Aim 1 will characterize pre-implementation baseline data only)
|
Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)
|
|
Change in clinician ratings to the Feasibility of Intervention Measure
Time Frame: Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)
|
ED clinician responses to the Feasibility of Intervention Measure (FIM), a 4 item scale with 5-point Likert-type items scaled from 1 (completely disagree) to 5 (completely agree).
Total scores reflect the mean item rating (range 1 to 5); higher scores reflect greater feasibility.
(Aim 2 outcome; Aim 1 will characterize pre-implementation baseline data only)
|
Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3.
- King NS, Crawford S, Wenden FJ, Moss NE, Wade DT. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995 Sep;242(9):587-92. doi: 10.1007/BF00868811.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Wounds and Injuries
- Pathologic Processes
- Disease Attributes
- Craniocerebral Trauma
- Trauma, Nervous System
- Head Injuries, Closed
- Wounds, Nonpenetrating
- Brain Injuries
- Pathological Conditions, Signs and Symptoms
- Brain Injuries, Traumatic
- Emergencies
- Brain Concussion
Other Study ID Numbers
- PRO00051478
- HT9425-24-1-0376 (Other Grant/Funding Number: U.S. Army Medical Research Acquisition Activity)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.